Additional file 1. Contains supplementary methods describing the Week 132 outcome (alternative outcome E), a comparison of the five alternative outcomes (Table S1), and sensitivity analyses for the FoR analysis in more detail. Also includes supplementary results in Table S2. Summary of secondary efficacy outcomes by treatment arm in MITT analysis population.
Phillips, P. P. J., Van Deun, A., Ahmed, S., Goodall, R. L., Meredith, S. K., Conradie, F., Chiang, C. Y., Rusen, I. D. & Nunn, A. J., Dec 1 2020, In: BMC Medicine.18, 1, 314.
Research output: Contribution to journal › Article › peer-review
Phillips, P. P. J. (Contributor), Deun, A. V. (Contributor), Ahmed, S. (Contributor), Goodall, R. L. (Contributor), Meredith, S. K. (Contributor), Conradie, F. (Contributor), Chiang, C. (Contributor), Rusen, I. D. (Contributor), Nunn, A. J. (Contributor) (Jan 1 2020). Additional file 1 of Investigation of the efficacy of the short regimen for rifampicin-resistant TB from the STREAM trial. Unknown Publisher. 10.6084/m9.figshare.13186016.v1